IPP Bureau
SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
By IPP Bureau - May 09, 2022
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Strengthening the access to rare disease treatment in India
By IPP Bureau - May 09, 2022
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
By IPP Bureau - May 09, 2022
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery
By IPP Bureau - May 09, 2022
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
Nanavati-Max Hospital, Mumbai to expand capacity by over 600 beds
By IPP Bureau - May 09, 2022
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
Mylab appoints Rajesh Patel as the Executive Director of In-Vitro Diagnostics Business
By IPP Bureau - May 09, 2022
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Premas Biotech appoints Saumen Chakraborty to its Board
By IPP Bureau - May 09, 2022
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
Aadi Bioscience announces collaborations with next generation sequencing leaders
By IPP Bureau - May 09, 2022
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
Lupin selects HPE GreenLake edge-to-cloud platform
By IPP Bureau - May 09, 2022
Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss
Challenges of Thalassemia management in India bring like-minded stakeholders together
By IPP Bureau - May 08, 2022
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City
By IPP Bureau - May 08, 2022
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Novavax submits variations to expand approval in Australia and New Zealand for adolescents
By IPP Bureau - May 08, 2022
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
Oncocyte completes validation of Therasure transplant monitor test
By IPP Bureau - May 08, 2022
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Quality issues force Novartis to suspend production of radioligand therapy medicines
By IPP Bureau - May 08, 2022
The production suspension impacts commercial and clinical trial supply
Lonza to sell processing plant in Quakertown, Pennsylvania
By IPP Bureau - May 08, 2022
Upon closing, the Quakertown business will become an independent company called Microsize
